BRUCINE SULFATE
Brucine sulfate is a salt form with similar pharmacologic and toxicologic properties. Exposure risks include CNS stimulation and seizures. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Brucine sulfate is a watersoluble salt of brucine, maintaining its potent glycinereceptor antagonist properties. Increased solubility enables more controlled dosing in in vitro and mechanistic neurotoxicity studies.
Benefits and advantages
Used in ligandbinding studies, reflexarc modelling, inhibitory neurotransmission research, neuroexcitation assays and saltform comparisons of toxic alkaloids.
Side effects and risks
Risks identical to brucine: extreme CNS toxicity, seizures, respiratory failure and rapid onset of convulsive activity. Handle with strict toxicalkaloid containment and PPE.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C46H54N4O12S |
|---|---|
| Molecular Weight | 887.0 g/mol |
| CAS Number | 4845-99-2 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Brucine sulfate; Brucine sulphate; 4845-99-2; KY7O12XPOQ; Brucine sulfate anhydrous |
| IUPAC/Chemical Name | bis((4aR,5aS,8aR,13aS,15aS,15bR)-10,11-dimethoxy-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one);sulfuric acid |
| InChl Key | HCMSIGALSOEZRW-WIMNQIPBSA-N |
| InChl Code | InChI=1S/2C23H26N2O4.H2O4S/c2*1-27-16-8-14-15(9-17(16)28-2)25-20(26)10-18-21-13-7-19-23(14,22(21)25)4-5-24(19)11-12(13)3-6-29-18;1-5(2,3)4/h2*3,8-9,13,18-19,21-22H,4-7,10-11H2,1-2H3;(H2,1,2,3,4)/t2*13-,18-,19-,21-,22-,23+;/m00./s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
